The 2021 edition of the World Health Organization (WHO) classification of central nervous system tumors introduces significant revisions across various tumor types. These updates, encompassing changes in diagnostic techniques, genomic integration, terminology, and grading, are crucial for radiologists, who play a critical role in interpreting brain tumor imaging. Such changes impact the diagnosis and management of nearly all central nervous system tumor categories, including the reclassification, addition, and removal of specific tumor entities. Given their pivotal role in patient care, radiologists must remain conversant with these revisions to effectively contribute to multidisciplinary tumor boards and collaborate with peers in neuro-oncology, neurosurgery, radiation oncology, and neuropathology. This knowledge is essential not only for accurate diagnosis and staging, but also for understanding the molecular and genetic underpinnings of tumors, which can influence treatment decisions and prognostication. This review, therefore, focuses on the most pertinent updates concerning the classification of adult diffuse gliomas, highlighting the aspects most relevant to radiological practice. Emphasis is placed on the implications of new genetic information on tumor behavior and imaging findings, providing necessary tools to stay abreast of advancements in the field. This comprehensive overview aims to enhance the radiologist’s ability to integrate new WHO classification criteria into everyday practice, ultimately improving patient outcomes through informed and precise imaging assessments.
25 April 2026 in American Journal of Neuroradiology
Visualization of cranial nerves III-VI (CN III-VI) within the orbit has traditionally been challenging on conventional MRI, even with advanced imaging techniques. Detailed nerve anatomy has largely been inferred from anatomical studies, while most previous MR imaging focused on proximal segments such as the cisternal or cavernous portions of CN III-VI. This study evaluated whether fat-suppressed three-dimensional (3D) FLAIR imaging obtained as part of brain MRI can depict these nerves. This retrospective, IRB-approved study included 46 subjects (92 orbits) without orbital disease who underwent brain MRI, including fat-suppressed 3D FLAIR imaging. Thirteen orbital structures were evaluated: the superior and inferior divisions and 5 orbital branches of the oculomotor nerve (CN III); trochlear nerve (CN IV); abducens nerve (CN VI); 3 branches of the ophthalmic nerve (CN V1) - frontal, lacrimal, nasociliary nerves; and the ciliary ganglion. Three independent readers scored each structure as 1 if identifiable or 0 if not, and detection rates and interobserver agreement were quantified using observed agreement and Gwet's AC1. The inferior and superior divisions of the oculomotor nerve and their branches (medial, inferior, and superior rectus branches), the abducens nerve, and the frontal nerve of V1 were identified in 100% of orbits, with observed agreement ranging from 83.7-98.9% and AC1 ranging from .87-.99. The trochlear nerve, ciliary ganglion, and lacrimal nerve were detected in 96.7-98.9% of orbits, with observed agreement of 78.3-81.5% and AC1 of .82-.84. Smaller or variable branches, including the inferior oblique and levator palpebrae superioris branches of CN III and the nasociliary nerve, showed detectability of 87.0-95.7%, with observed agreement of 17.4-38.0% and AC1 of -.08-.13. Fat-suppressed 3D FLAIR imaging acquired as part of brain MRI enables visualization of orbital nerves of CN III-VI and the ciliary ganglion without specialized sequences. This practical MR neurography approach may support future studies of orbital nerve anatomy and subtle abnormalities.